Replies to post #216000 on Cytodyn Inc (CYDY)

[HyGro]

Yeah, sure they are. BP can see the Phase 3 trial deficiencies. Even Merck has seen the data up close and personal and has already done several oncology deals that were NOT NWBO. If the results were so impressive, why would they be passing on it??